Tag Archives: Aubagio

IN BRIEF: FDA Just Approved Oral Relapsing Multiple Sclerosis Drug Aubagio

IN BRIEF: FDA Just Approved Oral Relapsing Multiple Sclerosis Drug Aubagio

Teriflunomide (Aubagio, Genzyme/Sanofi) is coming into the MS market [1]. It is an oral drug, nice. Efficacy:  “30% lower than the rate for those taking a placebo,” said Russell Katz, MD,”   What does that mean? Maybe not as clear as just a percent reduction in releases, think compounding. Sagepub …Read the Rest

© 2013-2019 Medical News Digest All Rights Reserved